Back to results
US 2006/0233753 A1Published application
Use of adenoviruses mutated in the va genes for cancer treatment
AssigneeOncolytics Biotech Inc.
InventorsRamon Bonastre, Manel Piqueras
Life of this patent
Estimating the term…
Abstract
This invention refers to the use of an adenovirus for cancer treatment, being this adenovirus defective in its virus-associated (VA) RNAs. Said adenovirus has a mutation in the VAI or VAII gene sequence or both. This adenovirus may also have mutations in the sequences controlling expression of the VA RNAs.
Claims11
A method of treating cancer comprising administering an adenovirus defective in its VAI and VAII virus-associated RNAs.
Dependencies are inferred from the claim text.